AstraZeneca’s COVID-19 vaccine is 79 percent effective in a U.S. trial
AstraZeneca’s COVID-19 vaccine is 79 percent effective in a U.S. trial The coronavirus vaccine developed by AstraZeneca and the University of Oxford was effective at preventing COVID-19 symptoms, a clinical trial of more than 30,000 people in the United States, Chile and Peru finds. It’s …..